Atrial natriuretic polypeptide inhibits hypertrophy of vascular smooth muscle cells.
Vascular remodeling is central to the pathophysiology of hypertension and atherosclerosis. Recent evidence suggests that vasoconstrictive substances, such as angiotensin II (AII), may function as a vascular smooth muscle growth promoting substance. To explore the role of the counterregulatory hormon...
I tiakina i:
| I whakaputaina i: | J Clin Invest |
|---|---|
| Ngā kaituhi matua: | , , |
| Hōputu: | Artigo |
| Reo: | Inglês |
| I whakaputaina: |
American Society for Clinical Investigation
1990
|
| Ngā marau: | |
| Urunga tuihono: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC296921/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2173726/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI114893 |
| Ngā Tūtohu: |
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|